These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 30876973

  • 1. Atrasentan alleviates high glucose-induced podocyte injury by the microRNA-21/forkhead box O1 axis.
    Wang J, Shen L, Hong H, Li J, Wang H, Li X.
    Eur J Pharmacol; 2019 Jun 05; 852():142-150. PubMed ID: 30876973
    [Abstract] [Full Text] [Related]

  • 2. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L, Fang J, Zhu B, Wang L, Chen J, Wang Y, Huang J, Wang H, Yao X.
    Life Sci; 2021 Mar 15; 269():119068. PubMed ID: 33476631
    [Abstract] [Full Text] [Related]

  • 3. LncRNA SOX2OT alleviates the high glucose-induced podocytes injury through autophagy induction by the miR-9/SIRT1 axis.
    Zhang Y, Chang B, Zhang J, Wu X.
    Exp Mol Pathol; 2019 Oct 15; 110():104283. PubMed ID: 31301307
    [Abstract] [Full Text] [Related]

  • 4. Protective effect of silencing Stat1 on high glucose-induced podocytes injury via Forkhead transcription factor O1-regulated the oxidative stress response.
    Wang H, Zhang Y, Xia F, Zhang W, Chen P, Yang G.
    BMC Mol Cell Biol; 2019 Jul 23; 20(1):27. PubMed ID: 31337338
    [Abstract] [Full Text] [Related]

  • 5. Long Noncoding RNA LINC01619 Regulates MicroRNA-27a/Forkhead Box Protein O1 and Endoplasmic Reticulum Stress-Mediated Podocyte Injury in Diabetic Nephropathy.
    Bai X, Geng J, Li X, Wan J, Liu J, Zhou Z, Liu X.
    Antioxid Redox Signal; 2018 Aug 01; 29(4):355-376. PubMed ID: 29334763
    [Abstract] [Full Text] [Related]

  • 6. Effects of overexpressing FoxO1 on apoptosis in glomeruli of diabetic mice and in podocytes cultured in high glucose medium.
    Li W, Wang Q, Du M, Ma X, Wu L, Guo F, Zhao S, Huang F, Wang H, Qin G.
    Biochem Biophys Res Commun; 2016 Sep 16; 478(2):612-7. PubMed ID: 27475499
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
    Zhang SZ, Qiu XJ, Dong SS, Zhou LN, Zhu Y, Wang MD, Jin LW.
    Eur Rev Med Pharmacol Sci; 2019 Feb 16; 23(3):1248-1256. PubMed ID: 30779094
    [Abstract] [Full Text] [Related]

  • 8. MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3.
    Wang L, Li H.
    Biosci Rep; 2020 Apr 30; 40(4):. PubMed ID: 32309847
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. M2 macrophage-derived exosomal miR-25-3p improves high glucose-induced podocytes injury through activation autophagy via inhibiting DUSP1 expression.
    Huang H, Liu H, Tang J, Xu W, Gan H, Fan Q, Zhang W.
    IUBMB Life; 2020 Dec 30; 72(12):2651-2662. PubMed ID: 33107695
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNA-770-5p contributes to podocyte injury via targeting E2F3 in diabetic nephropathy.
    Guo J, Han J, Liu J, Wang S.
    Braz J Med Biol Res; 2020 Dec 30; 53(9):e9360. PubMed ID: 32696822
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.
    Liu XD, Zhang LY, Zhu TC, Zhang RF, Wang SL, Bao Y.
    Int J Clin Exp Pathol; 2015 Dec 30; 8(5):4525-34. PubMed ID: 26191142
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hsa_circ_0037128 aggravates high glucose-induced podocytes injury in diabetic nephropathy through mediating miR-31-5p/KLF9.
    Fang R, Cao X, Zhu Y, Chen Q.
    Autoimmunity; 2022 Jun 30; 55(4):254-263. PubMed ID: 35285770
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.